Company intelligence / Profile preview

Kai Medical Laboratory

Dallas, Texas, United States

Ownership: Private
Development stage: Other

Overview

Kai Medical Laboratory provides high-complexity diagnostic testing and has an FDA Emergency Use Authorization (EUA) for its KAI Saliva COVID-19 PCR test; the company played a major role in federal, regional, and sector-wide COVID-19 compliance programs with rapid turnaround (24-48 hours) and scalable capacity, including tripling lab size to meet increased demand

Therapeutic areas: ImmunologyEndocrinologyInfectious DiseasesHematologyOther
Modalities: Device (Diagnostic kit)RT-PCR-based diagnosticsSerology-based diagnosticsLaboratory-developed tests
Industry: Molecular Diagnostics

Partnerships

Empower Clinics (parent relationship)regional partnerships in Arizonafederal, state, and county entities for COVID-19 testing (e.g., FDA, schools, airports)

Beyond the preview

Go deeper on Kai Medical Laboratory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kai Medical Laboratory.

Explore the full profile